Akums Drugs and Pharmaceuticals Q3 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
450.65
-13.70 (-2.95%)
-13.70 (-2.95%)Volume2.84 K
Updated: Fri 13 Feb, 2026 | 15:48:51
NSE
451.35-12.65 (-2.73%)
-12.65 (-2.73%)Volume70.72 K
Updated: Fri 13 Feb, 2026 | 15:48:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 23 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 928.79 | 1,958.27 | -1.51% |
| Depreciation/ Amortization | 44.52 | 60.14 | 27.69% |
| Operating Income | 81.63 | 192.87 | -9.32% |
| Net Income | 65.18 | -,156.42 | -0.04% |
| Other Operating Expenses Total | 111.05 | 29.09 | -18.25% |
| Net Income Before Taxes | 91.05 | -71.67 | -0.58% |
| Total Revenue | 1,010.41 | 2,151.14 | -2.19% |
| Selling/ General/ Admin Expenses Total | 175.60 | 445.60 | -2.50% |
| Diluted Normalized EPS | 4.03 | -8.82 | -3.75% |